Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Mitazalimab by Alligator Bioscience for Non-Small Cell Lung Cancer: Likelihood of Approval
Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Non-Small Cell Lung Cancer. According to...
Mitazalimab by Alligator Bioscience for Melanoma: Likelihood of Approval
Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Melanoma. According to GlobalData, Phase I...
Mitazalimab by Alligator Bioscience for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Kidney Cancer (Renal Cell Cancer). According...